Tevogen Inc.
TVGNW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001860871
No open-market purchases or sales by Tevogen Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $469.5K in total; no superinvestor holds it.
Other share classesTVGN
Q2 2026 vs. Q1 2026
How the institutions holding Tevogen Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 33 | 33 | 0 |
| Shares | 9.06M | 9.83M | +768.6K (+8.5%) |
| Value | $255.9K | $469.5K | +$213.6K (+83.5%) |
New holders (2)
Institutions that held Tevogen Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 100,000 | $5.68K | 0.00% |
| StoneX Group Inc. | 20,252 | $1.02K | 0.00% |
Sold out (2)
Institutions that held Tevogen Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Virtu Financial LLC | 78,473 | $3.00K |
| Toronto Dominion Bank | 100 | $3 |